Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)

Albert Deisseroth; Hagop Kantarjian; Richard Champlin; Fernando Cabanillas; Michael Keating; Chris Reading; Borje Andersson; David Claxton; Bud Robertson; Susan Escudier; Michael Andreeff; Susan O’brien; Steven Kornblau; Debra Ellerson; Elie Hanania; Siqing Fu

doi:10.1089/hum.1993.4.6-821

Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)

Albert Deisseroth, Hagop Kantarjian, Richard Champlin, Fernando Cabanillas, Michael Keating, Chris Reading, Borje Andersson, David Claxton, Bud Robertson, Susan Escudier, Michael Andreeff, Susan O’brien, Steven Kornblau, Debra Ellerson, Elie Hanania, Siqing Fu

Research output: Contribution to journal › Article

2 Scopus citations

Original language	English (US)
Pages (from-to)	821-834
Number of pages	14
Journal	Human Gene Therapy
Volume	4
Issue number	6
DOIs	https://doi.org/10.1089/hum.1993.4.6-821
State	Published - Jan 1 1993

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/hum.1993.4.6-821

Cite this

Deisseroth, A., Kantarjian, H., Champlin, R., Cabanillas, F., Keating, M., Reading, C., Andersson, B., Claxton, D., Robertson, B., Escudier, S., Andreeff, M., O’brien, S., Kornblau, S., Ellerson, D., Hanania, E., & Fu, S. (1993). Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). Human Gene Therapy, 4(6), 821-834. https://doi.org/10.1089/hum.1993.4.6-821

Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). / Deisseroth, Albert; Kantarjian, Hagop; Champlin, Richard; Cabanillas, Fernando; Keating, Michael; Reading, Chris; Andersson, Borje; Claxton, David; Robertson, Bud; Escudier, Susan; Andreeff, Michael; O’brien, Susan; Kornblau, Steven; Ellerson, Debra; Hanania, Elie; Fu, Siqing.

In: Human Gene Therapy, Vol. 4, No. 6, 01.01.1993, p. 821-834.

Research output: Contribution to journal › Article

Deisseroth, A, Kantarjian, H, Champlin, R, Cabanillas, F, Keating, M, Reading, C, Andersson, B, Claxton, D, Robertson, B, Escudier, S, Andreeff, M, O’brien, S, Kornblau, S, Ellerson, D, Hanania, E & Fu, S 1993, 'Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)', Human Gene Therapy, vol. 4, no. 6, pp. 821-834. https://doi.org/10.1089/hum.1993.4.6-821

Deisseroth A, Kantarjian H, Champlin R, Cabanillas F, Keating M, Reading C et al. Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). Human Gene Therapy. 1993 Jan 1;4(6):821-834. https://doi.org/10.1089/hum.1993.4.6-821

Deisseroth, Albert ; Kantarjian, Hagop ; Champlin, Richard ; Cabanillas, Fernando ; Keating, Michael ; Reading, Chris ; Andersson, Borje ; Claxton, David ; Robertson, Bud ; Escudier, Susan ; Andreeff, Michael ; O’brien, Susan ; Kornblau, Steven ; Ellerson, Debra ; Hanania, Elie ; Fu, Siqing. / Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). In: Human Gene Therapy. 1993 ; Vol. 4, No. 6. pp. 821-834.

@article{66a5cf6dea104518941f164a572304d4,

title = "Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)",

author = "Albert Deisseroth and Hagop Kantarjian and Richard Champlin and Fernando Cabanillas and Michael Keating and Chris Reading and Borje Andersson and David Claxton and Bud Robertson and Susan Escudier and Michael Andreeff and Susan O{\textquoteright}brien and Steven Kornblau and Debra Ellerson and Elie Hanania and Siqing Fu",

year = "1993",

month = jan,

day = "1",

doi = "10.1089/hum.1993.4.6-821",

language = "English (US)",

volume = "4",

pages = "821--834",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "6",

}

TY - JOUR

T1 - Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)

AU - Deisseroth, Albert

AU - Kantarjian, Hagop

AU - Champlin, Richard

AU - Cabanillas, Fernando

AU - Keating, Michael

AU - Reading, Chris

AU - Andersson, Borje

AU - Claxton, David

AU - Robertson, Bud

AU - Escudier, Susan

AU - Andreeff, Michael

AU - O’brien, Susan

AU - Kornblau, Steven

AU - Ellerson, Debra

AU - Hanania, Elie

AU - Fu, Siqing

PY - 1993/1/1

Y1 - 1993/1/1

UR - http://www.scopus.com/inward/record.url?scp=0027724911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027724911&partnerID=8YFLogxK

U2 - 10.1089/hum.1993.4.6-821

DO - 10.1089/hum.1993.4.6-821

M3 - Article

C2 - 8186294

AN - SCOPUS:0027724911

VL - 4

SP - 821

EP - 834

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -